News
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...
17h
TipRanks on MSNEurope Grants Limited Approval to Eli Lilly’s (LLY) Alzheimer’s Drug
But now, after re-examining the drug at the request of Eli Lilly, the medicines committee has recommended granting Kisunla ...
Shona also quoted doctor Tom Hildebrandt, who said he was seeing an increase in patients with eating disorders taking ...
Officials with the Indianapolis Public Schools recently announced that the district will receive more than $10 million from ...
Eli Lilly and Co. won the backing of European Union regulators for its Alzheimer’s disease drug Kisunla in a specific group ...
Four months after giving Eli Lilly’s Alzheimer’s disease treatment a thumbs-down, Europe’s Committee for Medicinal Products ...
Eli Lilly's donanemab gets CHMP backing for early Alzheimer's in select patients after trials show reduced disease ...
While fellow WNBA stars like Angel Reese and Cameron Brink have shown love for the dating show, Clark prefers a more low-key ...
23h
Zacks Investment Research on MSNEli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...
IL-17 inhibitors are approved for axial spondyloarthritis and psoriatic arthritis, but their effectiveness in heavily ...
Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...
European regulators said that Eli Lilly’s Alzheimer’s treatment Kisunla should be approved for select patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results